Japan Cell Culture Market
Japan Cell Culture Market by Product (Consumables [Media, Sera, Reagents, Vessels {Roller Bottle, Flask, Cell Factory}], Equipment [Bioreactors, Centrifuges, Filtration, Incubators]), Application (mAbs, Vaccines, CGT), End User - Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Japan cell culture market is projected to reach USD 2.34 billion by 2031 from USD 1.28 billion in 2026, at a CAGR of 12.8%. Cell culture refers to the process of growing cells under controlled conditions, typically outside their natural biological environment. This technique is fundamental to biological research, drug discovery, and biopharmaceutical production, as it enables scientists and manufacturers to study cellular behavior, evaluate therapeutic compounds, and produce biological products at scale.
KEY TAKEAWAYS
-
By ProductBy product, the sera, media, and reagent segment of consumables is projected to register the highest growth rate of 13.9% in the Japan cell culture market during the forecast period.
-
By ApplicationBy application, the biopharmaceutical production segment is projected to register the highest growth rate of 13.9% during the forecast period.
-
By End UserBy end user, the pharmaceutical and biotechnology companies held a share of 57.57% in 2025.
-
Competitive Landscape - Key PlayersThermo Fisher Scientific, Merck KGaA, and FUJIFILM Holdings were identified as leading players in the Japan cell culture market, given their strong market presence and comprehensive product portfolios.
-
Competitive Landscape - StartupsSeveral startups and small enterprises are contributing to market growth by focusing on specialized cell culture technologies and innovative solutions for specific research applications.
The Japan cell culture market is expanding steadily, driven by the rise in product launches, growing demand for regenerative medicine and cell-based therapies. Government support for biotechnology research, favorable regulatory pathways for cell therapy products, and rising investments in pharmaceutical and biopharmaceutical research are further accelerating demand for advanced cell culture systems and consumables across the country.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The Japan cell culture market is witnessing notable progress driven by continuous technological innovation and expanding adoption across the life sciences sector. Research organizations, pharmaceutical companies, and biotechnology firms in Japan are increasingly incorporating advanced cell culture techniques to support drug discovery and therapeutic development. Emerging technologies such as three-dimensional cell culture systems, automated culture platforms, and microfluidic technologies are gaining traction, enabling more precise and scalable experimental processes. In addition, the growing use of high-quality sera, optimized culture media, and specialized reagents is enhancing the ability of laboratories and biopharmaceutical manufacturers to develop biologically relevant cell models while improving cell growth, viability, and productivity. Regulatory support from government authorities, particularly through accelerated approval pathways established under the Pharmaceutical and Medical Devices Act, is further encouraging innovation and collaborative research efforts. These initiatives contribute to faster development cycles and facilitate the broader adoption of reliable and standardized cell culture technologies across Japan’s research and clinical landscape.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Growing popularity of monoclonal antibodies and biosimilars
-
Growth in advanced therapy medicinal products
Level
-
Ethical concerns associated with the utilization of specific cell types in scientific research
Level
-
Technological advancements in 3D cell culture systems and automated platforms
Level
-
Environmental impact and disposal of plastic consumables
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing popularity of monoclonal antibodies and biosimilars
The growing popularity of monoclonal antibodies and biosimilars is significantly driving demand for advanced cell culture technologies. Monoclonal antibodies are widely used in the treatment of cancer, autoimmune disorders, and other chronic diseases, increasing their production requirements. At the same time, the rising development of biosimilars is encouraging biopharmaceutical manufacturers to adopt efficient cell culture systems to support scalable, cost-effective biologics production.
Restraint: Ethical concerns associated with the utilization of specific cell types in scientific research
Ethical considerations related to the sourcing and use of certain cell types, particularly stem cells, present challenges for researchers and companies in Japan. Regulatory requirements and public sensitivity regarding cell sourcing necessitate careful compliance and transparent practices, which can affect research timelines and project feasibility.
Opportunity: Technological advancements in 3D cell culture systems and automated platforms
The development of advanced 3D cell culture systems, microfluidic technologies, and automated cell culture platforms presents significant growth opportunities in Japan. These innovations enhance the scalability, reproducibility, and physiological relevance of cell culture experiments, aligning well with the needs of pharmaceutical companies and research institutions seeking more efficient and predictive research tools.
Challenge: Environmental impact and disposal of plastic consumables
The management of environmental impacts associated with single-use plastic consumables represents a significant challenge for the cell culture industry in Japan. The substantial volume of disposable materials utilized in cell culture processes necessitates effective waste management practices. This has increased the focus on developing sustainable alternatives and improving disposal strategies to reduce environmental impact while ensuring that sterility, quality, and performance standards in laboratory and biopharmaceutical operations are maintained.
JAPAN CELL CULTURE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Supplies comprehensive cell culture media, sera, reagents, and bioreactor systems to pharmaceutical companies, research institutions, and biotechnology firms across Japan for applications in drug discovery, biopharmaceutical production, and regenerative medicine research | Provides reliable product quality, extensive technical support, and integrated solutions that enhance research productivity, support regulatory compliance, and enable efficient scale-up from research to commercial manufacturing |
 |
Offers specialized cell culture media, bioprocessing solutions, and quality control reagents to Japanese biopharmaceutical manufacturers and research organizations for monoclonal antibody production, vaccine development, and cell therapy manufacturing | Ensures consistent cell growth performance, supports process optimization, and provides regulatory-compliant materials that meet stringent quality standards required for therapeutic product development |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The Japan cell culture market is a collaborative ecosystem where suppliers, research institutions, pharmaceutical companies, biotechnology firms, and regulatory bodies work together to advance cell culture technologies and applications. Companies operating in Japan supply a variety of cell culture products, including consumables such as sera, media, and reagents and other consumables, as well as equipment such as bioreactors, incubators, and storage systems. Research institutions and universities conduct fundamental and applied research that advances cell culture methodologies and applications. Contract research organizations and contract development and manufacturing organizations support pharmaceutical and biotechnology companies in preclinical research, process development, and commercial-scale production. Ultimately, healthcare institutions and patients benefit from the therapies and products developed using these cell culture technologies, supported by regulatory frameworks that balance innovation with safety.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Japan Cell Culture Market, by Product
Consumables accounted for the largest share of the market in 2024, driven by the continuous demand for products such as sera, culture media, and reagents required for routine research and production activities. These materials play a critical role in maintaining cell viability and facilitating optimal cell growth across various applications, including pharmaceutical research, biopharmaceutical manufacturing, and academic research.
Japan Cell Culture Market, by Application
Biopharmaceutical production represented a significant segment of the Japan cell culture market. The increasing demand for biologics, including monoclonal antibodies, vaccines, and recombinant proteins, has driven substantial growth in this segment. Factors such as the rising prevalence of chronic diseases, an aging population requiring advanced therapeutics, and Japan's strong pharmaceutical manufacturing infrastructure are supporting the continued expansion of cell culture applications in biopharmaceutical production.
REGION
Japan to be fastest-growing region in Asia Pacific cell culture market during forecast period
Japan represents a fastest growing market in the Asia Pacific cell culture market during the forecast period, supported by its advanced biotechnology sector, strong pharmaceutical industry, and well-developed research infrastructure. The demand for cell culture products in Japan is increasing across biopharmaceutical manufacturing, vaccine production, diagnostics, and regenerative medicine applications. Moreover, substantial investments in life sciences research & development, along with the presence of leading academic institutions and biotechnology companies, are accelerating the adoption of advanced cell culture technologies from research laboratories to large-scale commercial manufacturing facilities.
JAPAN CELL CULTURE MARKET: COMPANY EVALUATION MATRIX
Thermo Fisher Scientific is a key player in the Japan cell culture market, providing a broad portfolio that includes cell culture media, sera, reagents, bioreactors, and automated systems for both research and biomanufacturing applications. The company benefits from well-established distribution channels in Japan and maintains collaborations with pharmaceutical companies, biotechnology firms, and research institutions across the country. Another key participant in the market is Fujifilm Holdings Corporation, which serves as a major domestic contributor. The company is enhancing its market presence through the expansion of its cell therapy manufacturing capabilities and the development of specialized solutions tailored for regenerative medicine and biopharmaceutical production.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific (US)
- Merck KGaA (Germany)
- FUJIFILM Holdings (Japan)
- BD & Co. (US)
- Lonza (Switzerland)
- Eppendorf (Germany)
- Sartorius AG (Germany)
- Corning Incorporated (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 1.28 billion |
| Market Forecast in 2030 (Value) | USD 2.34 billion |
| Growth Rate | CAGR of 12.8% from 2025–2030 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Contry Covered | Japan |
WHAT IS IN IT FOR YOU: JAPAN CELL CULTURE MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Understanding adoption patterns for cell culture technologies across Japanese research and manufacturing sectors | Assessed cell culture product usage trends across pharmaceutical companies, biotechnology firms, academic institutions, and contract manufacturing organizations in Japan, highlighting differences in adoption of consumables versus equipment and preferences for specific culture systems across biopharmaceutical production, regenerative medicine, and research applications | Helps clients align product development and marketing strategies with sector-specific requirements, budget considerations, and technology adoption patterns in the Japanese market |
| Identifying local distribution and partnership opportunities | Mapped regional distributors, contract research organizations, contract manufacturing organizations, and research institutions across Japan, with insights into supply chain dynamics, preferred supplier relationships, and collaboration models for cell culture products and services | Supports market entry strategies, identifies potential distribution partners, facilitates collaboration opportunities, and improves understanding of competitive positioning in the Japanese market |
RECENT DEVELOPMENTS
- December 2023 : FUJIFILM Corporation announced an investment of USD 200 million to expand its cell therapy manufacturing capacity in Japan, demonstrating the company's commitment to supporting the growing regenerative medicine sector and enhancing its capabilities in commercial-scale cell culture and processing.
- December 2023 : Takeda Pharmaceutical Company signed a memorandum of understanding with the Biotechnology Industry Research Assistance Council to promote healthcare innovation and collaborative research initiatives, supporting the advancement of cell-based therapies and biopharmaceutical development in the region.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the Japan cell culture market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Japan cell culture market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration, American Society for Cell Biology (ASCB), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT), American Society for Gene and Cell Therapy (ASGCT), Centers of Disease Control and Prevention (CDC), International Serum Industry Association (ISIA), Pharmaceutical Research and Manufacturers of America (PhRMA), International Society for Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Society for In Vitro Biology (SIVB), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), American Type Culture Collection (ATCC), and the Alliance for Regenerative Medicine (ARM); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
After acquiring foundational knowledge about the Japan cell culture market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biopharmaceutical companies, hospitals & diagnostic laboratories, research & academic institutes, and CROs. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.
These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Japan cell culture market. These methods were also used extensively to estimate the size of various subsegments in the market.
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Cell culture refers to removing cells from an animal or plant and their subsequent growth in an artificial environment under controlled conditions. It is a process of growing cells outside their natural environment, typically in a laboratory setting. This technique allows researchers to study cells in a controlled environment, providing insights into their behavior, growth, metabolism, and response to various stimuli.
Stakeholders
- Cell Culture Equipment and Reagents Manufacturers
- Analytical and Life Science Instrumentation Companies
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Life Science Companies
- Venture Capitalists and Investors
- Government Organizations
- Private Research Firms
- Contract Research Organizations (CROs)
- Hospitals and Diagnostic Laboratories
- Cell Banks
Report Objectives
- To define, describe, and forecast the Japan cell culture market based on the product, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall Japan cell culture market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the Japan cell culture market
- To benchmark players within the Japan cell culture market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product strategy.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Japan Cell Culture Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Still Researching the
Japan Cell Culture Ecosystem?
See the competitors, opportunity evaluation, and growth signals shaping it - Instantly!
Generate 15+ consulting-grade strategic intelligence outputs - from competitor analysis to board-ready strategy decks, tailored to your Japan Cell Culture growth question.
Growth opportunities and latent adjacency in Japan Cell Culture Market